Blood cell breakthrough could help treat heart disease

April 27, 2012

(Phys.org) -- Scientists at the University of Reading have made a groundbreaking discovery into the way blood clots are formed, potentially leading to the development of new drugs to treat one of the world's biggest killer illnesses.

Cardiovascular disease, which causes heart attacks and strokes, accounts for one in three of all deaths in the UK, often brought about by clots blocking major , preventing critical to the heart or brain.

Now researchers at the Institute for Cardiovascular and Metabolic Research (ICMR) at the University of Reading have uncovered, for the first time, the mechanism by which platelets, the that cause clots, ‘communicate' with each other and the inner walls of blood vessels when clotting.

The clotting process helps the body to repair itself and stops wounds from bleeding. But inappropriate activation of platelets leads to the formation of clots in the bloodstream (thrombosis), which can lead to a potentially fatal or stroke.

Currently, doctors treating heart disease can administer drugs which reduce the tendency of the blood to clot, and therefore decrease the risk of thrombosis.  However, such anti-thrombotic drugs are not effective for some patients, and can cause dangerous side-effects.

Professor Jonathan Gibbins and Dr. Sakthivel Vaiyapuri have headed up an international team of researchers that have discovered how platelets use specialised pore-like structures, called gap junctions, allowing direct communication between the cells. These structures have  been studied previously in other cells that are in constant contact with each other, but the researchers said their role in platelets was a ‘big surprise'.

The scientists, whose findings are published online in the journal Circulation, conclude that the discovery could lead to the creation of innovative to prevent or treat thrombosis.

Professor Gibbins said: "This appears to be a very important communication mechanism for blood clotting and thrombosis.  Since we have found that molecules that block these channels reduce thrombosis this may pave the way for potential new avenues for the development of more effective anti-thrombotic therapies to prevent heart attacks and strokes."

Dr. Vaiyapuri said: "Although this area of platelet research is still in its early stages, this is an exciting discovery.  The pore proteins have important functions in a range of cell types in the body, and therefore in the future it will be important to consider how to modulate the opening and closing of the pores specifically in platelets. "

Explore further: Cardiovascular disease linked to evolutionary changes that may have protected early mammals from trauma

Related Stories

Dental plaque bacteria may trigger blood clots

March 26, 2012

Oral bacteria that escape into the bloodstream are able to cause blood clots and trigger life-threatening endocarditis. Further research could lead to new drugs to tackle infective heart disease, say scientists presenting ...

Recommended for you

Scientists use 'virtual heart' to model heart failure

June 23, 2016

A team of researchers have created a detailed computational model of the electrophysiology of congestive heart failure, a leading cause of death. This "virtual heart" could help medical researchers study new drug therapies ...

Blacks with AFib at greater risk for adverse outcomes

June 22, 2016

Blacks with atrial fibrillation (AFib) have nearly double the risk than their white counterparts of stroke, heart failure, coronary heart disease (CHD) and mortality from all causes, according to a study published today in ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.